Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted

NCT02647489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Malaria, Antepartum

Interventions

BIOLOGICAL: PAMVAC
BIOLOGICAL: Alhydrogel
BIOLOGICAL: GLA-SE
BIOLOGICAL: GLA-LSQ
OTHER: Placebo

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]